Cardinal Health, Inc. filed its quarterly report on Form 10-Q with the SEC on November 5, 2026, covering the three-month period ended September 30, 2026, the first quarter of the company's fiscal year 2027.
Key Highlights
- Shares outstanding: As of October 31, 2026, Cardinal Health reported 231,136,655 common shares outstanding.
- Fiscal quarter covered: The filing covers the three months ended September 30, 2026, designated as Q1 of fiscal 2027, with the company's fiscal year ending June 30.
- Two reportable segments: The company reports results through its Pharmaceutical and Specialty Solutions segment and its Global Medical Products and Distribution segment, with Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight Logistics included in Other.
- Large accelerated filer: Cardinal Health is classified as a large accelerated filer, according to the filing's cover page.
- Comparisons referenced: Financial condition comparisons are drawn between September 30, 2026 and June 30, 2026 balance sheet dates, and results of operations comparisons cover the three months ended September 30, 2026 versus September 30, 2025.
Cardinal Health's Q1 Fiscal 2027 Quarterly Disclosure: Segments, Structure, and Filing Details
Cardinal Health, Inc. (NYSE:CAH), an Ohio corporation formed in 1979, filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 5, 2026. The filing identifies the company as "a global healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home," according to the registrant's own description.
The company disclosed 231,136,655 common shares without par value outstanding as of October 31, 2026. Its principal executive offices remain at 7000 Cardinal Place, Dublin, Ohio 43017. The filing confirms the company has filed all reports required by the Securities Exchange Act of 1934 during the preceding 12 months and has submitted all required Interactive Data Files electronically.
According to the filing, Cardinal Health's two reportable segments are the Pharmaceutical and Specialty Solutions segment, which distributes branded, generic, and specialty pharmaceutical products in the United States and provides related services, and the Global Medical Products and Distribution segment, which manufactures, sources, and distributes Cardinal Health brand medical, surgical, and laboratory products in the United States, Canada, Europe, Asia, and other markets. The filing notes that forward-looking statements in the document "speak only as of the date of this document" and are subject to risks and uncertainties described in the Form 10-Q and in the company's 2026 Form 10-K.
What Was Disclosed
Cardinal Health filed its Q1 fiscal 2027 Form 10-Q covering the three months ended September 30, 2026, disclosing 231,136,655 shares outstanding as of October 31, 2026, its two-segment operating structure, and the comparative periods used in its financial analysis.



Please wait processing your request...